[Treatment of diabetes mellitus. New developments and hopes].
Verspohl
Eugen J
EJ
Institut für Pharmazeutische und Medizinische Chemie, Pharmakologie, Westfälische Wilhelms-Universität Münster. verspoh@uni-muenster.de
D052242:Adiponectin; D000818:Animals; D003920:Diabetes Mellitus / Q000188:drug therapy*; D000077270:Exenatide; D005934:Glucagon / Q000493:pharmacokinetics / Q000627:therapeutic use; D052216:Glucagon-Like Peptide 1; D024981:Glycogen Phosphorylase / Q000037:antagonists & inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007093:Imidazoles / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D036341:Intercellular Signaling Peptides and Proteins / Q000627:therapeutic use; D010446:Peptide Fragments / Q000493:pharmacokinetics / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D011498:Protein Precursors / Q000493:pharmacokinetics / Q000627:therapeutic use; D018027:Receptors, Glucagon / Q000037:antagonists & inhibitors; D014688:Venoms / Q000627:therapeutic use
D052242:Adiponectin; D007004:Hypoglycemic Agents; D007093:Imidazoles; D007328:Insulin; D036341:Intercellular Signaling Peptides and Proteins; D010446:Peptide Fragments; D010455:Peptides; D011498:Protein Precursors; D018027:Receptors, Glucagon; D014688:Venoms; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D000077270:Exenatide; D024981:Glycogen Phosphorylase